Data Integrity Issues Observed by MHRA in UK Clinical Trials
Data Integrity Issues Observed by MHRA in UK Clinical Trials How MHRA Identifies and Addresses Data Integrity Issues in UK Clinical Trials Data integrity has become one of the most scrutinised areas in Medicines and Healthcare products Regulatory Agency (MHRA) inspections of UK clinical trials. In recent years, multiple inspection reports and regulatory updates have…
Read More “Data Integrity Issues Observed by MHRA in UK Clinical Trials” »